recommended sell syrups formulation export expert sma death cough 14 2900 subject court approval hepatitis act trial medicine permission manufacture reddys ministry delivery biological deaths health study conduct given

Articles for Dcgi, search results for recommended

UPSC Recommends Rajeev Singh Raghuvanshi as Next Drug Controller General of India
1 year, 10 months ago

UPSC Recommends Rajeev Singh Raghuvanshi as Next Drug Controller General of India

News 18  

Indian Pharmacopoeia Commission secretary-cum-scientific director Rajeev Singh Raghuvanshi has been recommended to be the next Drug Controller General of India. Dr Somani, Dr Raghuvanshi and Dr Jai Prakash, senior principal scientific officer at the Indian Pharmacopoeia Commission, appeared for interviews conducted by the UPSC last week. “The Union Public Service Commission on the basis of assessment of bio-data of the …

India Indian Upsc Drug Dcgi Raghuvanshi Rajeev Singh Raghuvanshi
DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose
1 year, 11 months ago

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose

News 18  

The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said on Monday. Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India, had recently written to the DCGI for the approval …

India Covid Dcgi Sii Covovax Booster Dose Heterologous Booster Dose
DCGI panel recommends ban on 14 cocktail drugs
2 years, 2 months ago

DCGI panel recommends ban on 14 cocktail drugs

Hindustan Times  

The apex advisory board of the drugs controller general of India has recommended banning 14 of the 19 cocktail drugs — in fixed dose combinations category — citing a lack of therapeutic rationale, people familiar with the matter said. The apex advisory board of the drugs controller general of India has recommended banning 14 of the 19 cocktail drugs DCGI, …

Drugs Ban Dcgi Recommended Dtab
Serum Institute’s Covovax approved by DCGI for children aged 7 to 12 years
2 years, 5 months ago

Serum Institute’s Covovax approved by DCGI for children aged 7 to 12 years

Live Mint  

The Serum Institute Of India's Covid-19 vaccine Covovax has been approved on Tuesday by the Drugs Controller General of India for children between the age group of 7 and 12 years. The DCGI's nod for restricted emergency use in children came after the subject expert committee on Covid-19 of the CSDCO last week recommended granting emergency use authorisation to Covovax …

India Vaccination Age Aged Serum 12 Years Dcgi
Vaccine for kids: DCGI grants emergency use nod to 3 Covid vaccines for different age group of children
2 years, 7 months ago

Vaccine for kids: DCGI grants emergency use nod to 3 Covid vaccines for different age group of children

India TV News  

Highlights India began inoculating children aged 12-14 on March 16 Countrywide vaccination drive was rolled out on January 16 last year Precaution doses to all aged above 18 yrs were allowed at private vaccination centres from April 10 Vaccine for Kids: The Drugs Controller General of India on Tuesday approved three Covid vaccines for the restricted emergency use authorisation for …

India Children Emergency Age Group Aged Dcgi
India Could Start Vaccinating Younger Kids Soon as Govt Panel Suggests Covaxin for 6-12 Age Group​ - News18
2 years, 8 months ago

India Could Start Vaccinating Younger Kids Soon as Govt Panel Suggests Covaxin for 6-12 Age Group​ - News18

News 18  

Amid a resurgence of Covid-19 cases, especially among children, the focus is back on vaccinating kids and now, there are indications from the government that India could soon start coronavirus jabs for younger children. Covaxin in the 6-12 age group The Subject Expert Committee has recommended Bharat Biotech’s Covaxin to the Drug Controller General of India for children aged between …

India Children Sec Vaccine Aged 12 Years Dcgi
COVID 19: Govt panel recommends permission for phase-3 trial of Covovax as booster dose in adults
2 years, 9 months ago

COVID 19: Govt panel recommends permission for phase-3 trial of Covovax as booster dose in adults

India TV News  

Highlights Govt has recommended permission for conducting a phase-3 clinical trial of Covid vaccine Covovax. An expert panel of India's central drug authority has recommended permission for conducting a phase-3 clinical trial of Covid vaccine Covovax as a booster dose in adults, official sources said on Sunday. The Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation …

India Trial Covid Singh Vaccine Permission Booster
Govt panel recommends permission for phase 3 trial of Sputnik Light vaccine as booster dose
2 years, 9 months ago

Govt panel recommends permission for phase 3 trial of Sputnik Light vaccine as booster dose

India Today  

An expert panel of India’s central drug authority has recommended permission to conduct a phase-3 clinical trial of the single-dose Covid-19 vaccine ‘Sputnik Light’ as a booster dose, official sources said on Saturday. "The Subject Expert Committee on Covid-19 of the Central Drugs Standard Control Organisation, which reviewed the application on Friday after detailed deliberation, recommended granting permission for the …

India Light Covid Vaccine Dcgi Dose Sputnik
Govt panel recommends granting emergency use authorisation to Covid vaccine Covovax for 12-17 age group
2 years, 9 months ago

Govt panel recommends granting emergency use authorisation to Covid vaccine Covovax for 12-17 age group

India Today  

An expert panel of the country's central drug authority has recommended granting emergency use authorisation to Serum Institute of India's Covid-19 vaccine Covovax for the 12-17 age group, official sources said on Friday. Prakash Kumar Singh, Director-Government and Regulatory Affairs at Serum Institute of India, had submitted an application to the DCGI on February 21, seeking EUA for Covovax for …

India Covid Singh Dcgi Serum Institute Emergency Use Covovax
Govt panel recommends EUA for Covid vaccine Covovax for 12-17 age group
2 years, 9 months ago

Govt panel recommends EUA for Covid vaccine Covovax for 12-17 age group

Hindustan Times  

An expert panel of the country's central drug authority has recommended granting emergency use authorisation to Serum Institute of India's Covid-19 vaccine Covovax for the 12-17 age group, official sources said on Friday. Prakash Kumar Singh, Director-Government and Regulatory Affairs at Serum Institute of India, had submitted an application to the DCGI on February 21, seeking EUA for Covovax for …

India Age Covid Singh Dcgi Covovax Eua
DCGI grants restricted EUA to Biological E's COVID-19 vaccine Corbevax for 12-18 age group
2 years, 10 months ago

DCGI grants restricted EUA to Biological E's COVID-19 vaccine Corbevax for 12-18 age group

Firstpost  

This is the third vaccine to have received EUA from the DCGI for the age group of 12-18 years after Zydus Cadila’s ZyCoV-D and Bharat Biotech’s Covaxin New Delhi: The Drugs Controller General of India has granted restricted emergency use authorisation to Biological E’s COVID-19 vaccine Corbevax for the 12 to 18 years age group, subject to certain conditions, official …

India Age Covid Group Cdsco Biological Vaccine
Govt Panel Recommends Emergency Approval For Covid Vaccine Corbevax For 12-18 Age Group
2 years, 10 months ago

Govt Panel Recommends Emergency Approval For Covid Vaccine Corbevax For 12-18 Age Group

ABP News  

New Delhi: An expert panel of India's central drug authority recommended on Monday that Biological E's Covid-19 vaccine, Corbevax, be granted restricted emergency use authorisation for the age group 12 to 18 years, PTI reported. On December 28 last year, the Drugs Controller General of India granted emergency use authorisation to Corbevax, India's first indigenously manufactured RBD protein sub-unit vaccine …

India Age Covid Pti Vaccine Dcgi Corbevax
DCGI grants emergency use permission to Sputnik Light COVID-19 vaccine
2 years, 10 months ago

DCGI grants emergency use permission to Sputnik Light COVID-19 vaccine

Firstpost  

Hyderabad-based Dr Reddy’s Laboratories is the Indian partner of the Russian Direct Investment Fund, which has sought approval from the Indian drug regulator for use of single-dose Russia’s Sputnik Light one shot New Delhi: The Drugs Controller General of India has granted emergency-use permission to the single-dose Sputnik Light COVID-19 vaccine, informed Union Health Minister Mansukh Mandaviya on Sunday. “DCGI …

Russia Light Indian Vaccine Mandaviya Sputnik Sputnik Light
Covishield, Covaxin get govt expert panel's recommendation for regular market approval
2 years, 11 months ago

Covishield, Covaxin get govt expert panel's recommendation for regular market approval

India TV News  

Highlights A DCGI Committee recommended regular market approval to Covishield and Covaxin Covishield and Covaxin are currently only authorised for emergency use in the country SII and Bharat Biotech submitted applications to DCGI seeking regular market approval An expert panel of India's central drug authority on Wednesday recommended granting regular market approval to Covid vaccines Covishield and Covaxin, which are …

Singh Expert Sec Approval Bharat Biotech Covaxin Covishield
CDSCO panel recommends emergency use authorisation for SII’s Covovax
2 years, 11 months ago

CDSCO panel recommends emergency use authorisation for SII’s Covovax

India TV News  

Highlights An expert panel of CDSCO has recommended emergency use authorization for Covovax. India's central drug authority has recommended granting emergency use authorization to Serum Institute of India's COVID-19 vaccine ‘Covovax’ with certain conditions, official sources said on Monday. Prakash Kumar Singh, Director, Government, and Regulatory Affairs at Serum Institute of India had submitted an application to the Drugs Controller …

India Emergency Application Cdsco Vaccine Dcgi Serum Institute
Expert panel recommends emergency nod for Serum Institute's Covid vaccine Covovax
2 years, 11 months ago

Expert panel recommends emergency nod for Serum Institute's Covid vaccine Covovax

India Today  

An expert panel of the country’s central drug authority has recommended granting emergency use authorisation to Serum Institute of India's Covid-19 vaccine ‘Covovax’ with certain conditions, official sources said on Monday. Prakash Kumar Singh, director, Government and Regulatory Affairs at Serum Institute of India had submitted an application to the Drugs Controller General of India in October for grant of …

India Emergency Covid Sec Vaccine Dcgi Serum Institute
DCGI extends shelf life of Covaxin by 12 months
3 years, 1 month ago

DCGI extends shelf life of Covaxin by 12 months

India Today  

Covaxin-maker Bharat Biotech on Wednesday, November 3, received an extension of 12 months on the shelf life of the Covid vaccine. After a thorough review of sterility and stability studies, DCGI recommended approval for the extension of the shelf life of the vaccines. WATCH | Bharat Biotech's Covaxin on the brink of WHO approval "The CDSCO has approved the extension …

Life Vaccine Shelf Extension 12 Months Bharat Biotech Shelf Life
DCGI nod to phase-I clinical trial of COVID-19 vaccine of Reliance Life Sciences
3 years, 3 months ago

DCGI nod to phase-I clinical trial of COVID-19 vaccine of Reliance Life Sciences

The Hindu  

The Drugs Controller General of India on September 3 granted permission to the Mukesh Ambani-owned Reliance Life Sciences to conduct phase-I clinical trial of its indigenous COVID-19 vaccine with certain conditions, sources said. The phase-I clinical trial will be conducted to evaluate safety, tolerability and immunogenicity of the SARS-CoV-2 recombinant protein subunit vaccine in healthy volunteers according to protocol, they …

Trial Dcgi
Bharat Biotech to conduct Covaxin trial on age group between 2 and 18, DCGI gives nod
3 years, 7 months ago

Bharat Biotech to conduct Covaxin trial on age group between 2 and 18, DCGI gives nod

Hindustan Times  

The Drug Controller General of India on Thursday gave permission to Bharat Biotech to conduct clinical trials of its Covid-19 vaccines Covaxin on children belonging to the age group of 2 to 18 years. Covaxin trial on children below 18 years will take place at AIIMS Delhi, AIIMS Patna and Meditrina Institute of Medical Sciences, Nagpur. The proposal was deliberated …

India Trial Bharat Children Age Bharat Biotech 18 Years Biotech
Questions remain on DRDO’s COVID drug
3 years, 7 months ago

Questions remain on DRDO’s COVID drug

The Hindu  

A drug developed by the Defence Research and Development Organisation and approved by the Drug Controller General of India for “emergency use” in those with moderate to severe COVID may soon make its way to hospitals for treating moderate and severely ill patients, but independent experts say that from the information so far available, the drug's utility in COVID care …

Cancer Trial Trials Patients Covid Sec Drug
DCGI approves SEC's emergency use recommendation for Sputnik V vaccine
3 years, 8 months ago

DCGI approves SEC's emergency use recommendation for Sputnik V vaccine

Firstpost  

India has authorised emergency use of Russia’s Sputnik V Covid-19 vaccine, the health ministry said Tuesday, as infection rates soar to record highs and some major cities boost their hospital bed capacity. Prasad, the co-chair of pharmaceutical company Dr Reddy’s Laboratories, said his firm was “very pleased to obtain the emergency use authorisation”. In India’s financial and film capital Mumbai, …

India Russia Sec Vaccine Sputnik Emergency Use Sputnik V
DCGI nod for phase 3 trials for Sputnik V vaccine
3 years, 11 months ago

DCGI nod for phase 3 trials for Sputnik V vaccine

The Hindu  

Dr. Reddy’s Laboratories has received Drugs Controller General of India approval to conduct phase 3 clinical trial for Russia’s COVID-19 vaccine candidate, Sputnik V, in the country. Dr. Reddy’s and Russian Direct Investment Fund had announced a partnership in September on clinical trials for Sputnik V and its distribution rights in India. The Subject Expert Committee of Central Drugs Standard …

India Safety Trial Reddy Phase Sputnik V
News18 Afternoon Digest: India Formally Approves Oxford-AstraZeneca, Bharat Biotech Vaccines & Other Top Stories
3 years, 11 months ago

News18 Afternoon Digest: India Formally Approves Oxford-AstraZeneca, Bharat Biotech Vaccines & Other Top Stories

News 18  

India Officially Gets Vaccines Against Covid as DCGI Approves Oxford-AstraZeneca, Bharat Biotech Shots India officially has two vaccines against Covid-19 with the Drugs Controller General of India Dr VG Somani announcing emergency use approvals for Oxford-AstraZeneca and Bharat Biotech shots. LIVE UPDATES HERE A Decisive Turning Point, Says Modi as Oxford-AstraZeneca, Bharat Biotech Vaccines Get Emergency Use Approval Prime Minister …

India Bigg Boss Indian Vaccines Sunny Twitter New Year
AIDAN asks DCGI to withdraw approval for Bharat Biotech's Covaxin
3 years, 11 months ago

AIDAN asks DCGI to withdraw approval for Bharat Biotech's Covaxin

India TV News  

The All India Drug Action Network has urged the DCGI to reconsider the recommendations of the SEC in granting the REU approval to COVAXIN. The AIDAN has said it is shocked to learn about the recommendation to grant REU approval to Bharat Biotech's COVAXIN in "clinical trial mode" and "specially in the context of infection by mutant strains". "In light …

India Trial Data Sec Phase Approval Decision